fulvestrant,palbociclib
pfizer
[' fulv', 'bcsm', 'palbo']
esr1 mutations in pada-1 study ctdna checked every 2 months while on ai + palbo:
when esr1 rising, randomized to change to fulvestrant or continue ai improved pfs and pfs2 if change to fulvestrant francois-clement bidard #asco23 #bcsm 
Medical oncologist @Intermountain, Director of Breast Oncology. Clinical research, quality improvement, cardio-oncology, provider wellness. All tweets my own.